Home
Invus Global Management reported a 6.3% stake in enGene Therapeutics ENGN · 4,244,559 sh · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive
- Stake
- 6.3%
- Last report
- First report
- Shares held
- 4,244,559 sh
- Class
- Common Shares
- Holder
- Invus Global Management
- Event date
- 26/01/21
- Filed
- 26/01/27
First 5%+ report · 6.3% stake
enGene Therapeutics trades, last 26 weeks
What else happened in enGene Therapeutics around then
Filed or reported within 30 days of the trade day · 25/12/22~02/20Invus Global Management's other 5% stake reports
- Invus Global Management
5% stakeYarrow Bioscience
5% stakeYarrow Bioscience
YARW
7.2% stake
675,000 sh
7.2% stake
Filed 09/17
- Invus Global Management
5% stakeenGene Therapeutics
5% stakeenGene Therapeutics
ENGN
9.3% stake
6,256,662 sh
9.3% stake
Filed 08/13
- Invus Global Management
5% stakeScholar Rock Holding
5% stakeScholar Rock Holding
SRRK
8% stake
9,575,013 sh
8% stake
Filed 08/13
- Invus Global Management
5% stakeAbivax
5% stakeAbivax
ABVX
6% stake
4,825,759 sh
6% stake
Filed 08/13
- Invus Global Management
5% stakeHemab Therapeutics Holdings
5% stakeHemab Therapeutics Holdings
COAG
5.1% stake
2,366,235 sh
5.1% stake
Filed 08/07
